Launch Preparation
Pressure-test launch readiness, sequence go-to-market priorities, and align medical and commercial around one plan.
The Problem We Solve
In a few weeks: a pressure-tested go-to-market plan and a sequenced readiness roadmap — not a quarter of workshops.
You call us when it's your first launch, the team is small, and there's no internal playbook. When a launch plan exists but has never been challenged by someone who has done this at scale. When medical and commercial preparation are advancing on separate tracks. Or when a new indication, device or formulation must find its place inside an existing franchise.
Deliverables:
Go-to-market options and sequencing
Launch-readiness diagnostic
Critical path: what must be true, by when
Medical–commercial alignment plan
Stakeholder and KOL engagement logic
How it works
Step 1
Audit
Launch readiness assessed against a field-tested framework: evidence, access, customer, organization.
Step 2
Gaps
What's missing, ranked by what actually threatens the launch — not by what's easiest to fix.
Step 3
Sequence
The go-to-market path and its critical milestones, sized to your team and your budget.
Step 4
Alignment
One plan, one calendar, medical and commercial in the same room before you leave ours.
You call us when the data is strong but the value story changes depending on who tells it. When partnering or fundraising discussions are coming and the commercial narrative lags the science. When an established standard of care makes differentiation harder than the clinical profile suggests. Or when a brand plan exists on paper but does not drive choices in the field.
Behind this practice: go-to-market leadership for a subcutaneous device and a rare-disease indication within a franchise that grew from $1B to $4.5B — and launch-team leadership for new indications and formulations on one of the world's largest biologics.
